Thrombosis and Haemostasis

LinksSchließen

Referenz

Mahalingam D, Patel M, Sachdev J. , et al.
Safety and efficacy analysis of imalumab, an anti-oxidized macrophage migration inhibitory factor (oxMIF) antibody, alone or in combination with 5-fluorouracil/leucovorin (5-FU/LV) or panitumumab, in patients with metastatic colorectal cancer (mCRC).

Ann Oncol 2016;
2016: ii105

Bibliographische Angaben herunterladen

Suchen in: